Considered tumor suppressor genes, the inactivation of BRCA1 and BRCA2 after loss of heterozygosity confer a risk of 56 to 87% of development of breast cancer in women and somatic mutations of BRCA2 are associated with aggressive metastasis in lymph nodes in humans [34]. The gene discussed is BRCA2; the disease is neoplasm.